Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Breast Neoplasms | 16 | 2021 | 3633 | 3.29 | Why? |
Mastectomy | 6 | 2021 | 536 | 2.19 | Why? |
Treatment Refusal | 2 | 2020 | 211 | 1.37 | Why? |
Carcinoma, Ductal, Breast | 2 | 2018 | 149 | 1.22 | Why? |
Biopsy, Large-Core Needle | 2 | 2020 | 81 | 0.87 | Why? |
Neoadjuvant Therapy | 2 | 2021 | 554 | 0.87 | Why? |
Sentinel Lymph Node Biopsy | 2 | 2020 | 173 | 0.84 | Why? |
Fluorodeoxyglucose F18 | 2 | 2018 | 1153 | 0.81 | Why? |
Lymphatic Metastasis | 5 | 2021 | 537 | 0.80 | Why? |
Receptor, ErbB-2 | 2 | 2018 | 267 | 0.77 | Why? |
Sentinel Lymph Node | 1 | 2018 | 35 | 0.71 | Why? |
Positron Emission Tomography Computed Tomography | 2 | 2018 | 1458 | 0.69 | Why? |
Mammaplasty | 1 | 2021 | 224 | 0.69 | Why? |
Molecular Probes | 1 | 2017 | 106 | 0.60 | Why? |
Lymph Nodes | 2 | 2020 | 1060 | 0.59 | Why? |
Hospitals, Urban | 1 | 2020 | 950 | 0.56 | Why? |
Surgery, Computer-Assisted | 1 | 2017 | 183 | 0.55 | Why? |
Axilla | 3 | 2020 | 198 | 0.54 | Why? |
Bone Neoplasms | 1 | 2017 | 287 | 0.53 | Why? |
Lymph Node Excision | 3 | 2020 | 362 | 0.50 | Why? |
Mammography | 4 | 2020 | 410 | 0.50 | Why? |
Mass Screening | 3 | 2020 | 8005 | 0.46 | Why? |
Elective Surgical Procedures | 2 | 2020 | 5338 | 0.46 | Why? |
Early Detection of Cancer | 2 | 2020 | 1956 | 0.45 | Why? |
Cancer Care Facilities | 1 | 2020 | 1190 | 0.45 | Why? |
Surgery Department, Hospital | 1 | 2020 | 954 | 0.42 | Why? |
Neoplasm Recurrence, Local | 1 | 2017 | 1063 | 0.39 | Why? |
Carcinoma, Intraductal, Noninfiltrating | 2 | 2020 | 98 | 0.38 | Why? |
Rome | 2 | 2020 | 497 | 0.37 | Why? |
Lymphocytes | 1 | 2021 | 3056 | 0.34 | Why? |
Hospitals, University | 1 | 2020 | 4173 | 0.34 | Why? |
Personnel, Hospital | 1 | 2020 | 2273 | 0.32 | Why? |
Patient Care Team | 1 | 2020 | 3556 | 0.30 | Why? |
Decision Making | 1 | 2020 | 3132 | 0.30 | Why? |
Wakefulness | 2 | 2020 | 598 | 0.29 | Why? |
Antineoplastic Agents | 1 | 2021 | 3550 | 0.29 | Why? |
Fear | 1 | 2020 | 3607 | 0.28 | Why? |
Occupational Diseases | 1 | 2020 | 2787 | 0.28 | Why? |
Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.28 | Why? |
Neoplasm Staging | 2 | 2021 | 1999 | 0.24 | Why? |
Interleukin-6 | 1 | 2021 | 7522 | 0.24 | Why? |
Breast | 2 | 2021 | 290 | 0.23 | Why? |
Splenic Artery | 1 | 2021 | 18 | 0.23 | Why? |
Combined Modality Therapy | 2 | 2021 | 3395 | 0.22 | Why? |
Neoplasms, Hormone-Dependent | 1 | 2020 | 25 | 0.22 | Why? |
Mesenteric Veins | 1 | 2021 | 60 | 0.21 | Why? |
Mesenteric Vascular Occlusion | 1 | 2021 | 43 | 0.21 | Why? |
Ultrasonography, Mammary | 1 | 2020 | 31 | 0.21 | Why? |
Vacuum | 1 | 2020 | 60 | 0.21 | Why? |
Female | 21 | 2021 | 380317 | 0.21 | Why? |
Health Systems Plans | 1 | 2020 | 56 | 0.21 | Why? |
Mastectomy, Segmental | 1 | 2020 | 124 | 0.21 | Why? |
Health Policy | 1 | 2020 | 6242 | 0.21 | Why? |
Lung Neoplasms | 1 | 2017 | 3228 | 0.21 | Why? |
Tumor Burden | 1 | 2021 | 369 | 0.20 | Why? |
Triple Negative Breast Neoplasms | 1 | 2020 | 92 | 0.19 | Why? |
Antineoplastic Agents, Hormonal | 1 | 2021 | 203 | 0.19 | Why? |
Carcinoma in Situ | 1 | 2019 | 58 | 0.19 | Why? |
Breast Neoplasms, Male | 1 | 2018 | 48 | 0.19 | Why? |
Drug Therapy | 1 | 2021 | 280 | 0.19 | Why? |
Anesthesia, Local | 1 | 2020 | 163 | 0.19 | Why? |
Precancerous Conditions | 1 | 2019 | 108 | 0.18 | Why? |
Operative Time | 1 | 2020 | 450 | 0.18 | Why? |
Aged | 14 | 2021 | 215776 | 0.18 | Why? |
Retrospective Studies | 8 | 2021 | 105322 | 0.18 | Why? |
Middle Aged | 14 | 2021 | 270681 | 0.18 | Why? |
Coronavirus Infections | 7 | 2021 | 253789 | 0.18 | Why? |
Surgical Mesh | 1 | 2017 | 55 | 0.18 | Why? |
Hematoma | 1 | 2021 | 305 | 0.17 | Why? |
Mechanical Phenomena | 1 | 2017 | 50 | 0.17 | Why? |
Anxiety | 2 | 2021 | 17311 | 0.17 | Why? |
Nerve Block | 1 | 2020 | 183 | 0.17 | Why? |
Aged, 80 and over | 8 | 2021 | 88759 | 0.17 | Why? |
Estrogens | 1 | 2020 | 252 | 0.16 | Why? |
Pandemics | 10 | 2021 | 389249 | 0.16 | Why? |
Carcinoma | 1 | 2020 | 256 | 0.16 | Why? |
Spleen | 1 | 2021 | 877 | 0.16 | Why? |
Protective Devices | 1 | 2020 | 493 | 0.15 | Why? |
Tissue Engineering | 1 | 2017 | 190 | 0.15 | Why? |
Italy | 4 | 2020 | 38444 | 0.15 | Why? |
Pneumonia, Viral | 6 | 2020 | 243684 | 0.15 | Why? |
Emergency Service, Hospital | 1 | 2020 | 14232 | 0.15 | Why? |
Pericardium | 1 | 2017 | 228 | 0.15 | Why? |
Tissue Distribution | 1 | 2017 | 483 | 0.14 | Why? |
Neoplasm Metastasis | 1 | 2017 | 682 | 0.13 | Why? |
Psychosocial Support Systems | 1 | 2020 | 710 | 0.13 | Why? |
Quarantine | 1 | 2020 | 18418 | 0.13 | Why? |
Humans | 21 | 2021 | 930598 | 0.13 | Why? |
Neoplasms | 1 | 2021 | 17251 | 0.12 | Why? |
Radiopharmaceuticals | 1 | 2017 | 763 | 0.11 | Why? |
Coronavirus | 1 | 2021 | 18339 | 0.11 | Why? |
Prognosis | 3 | 2021 | 32490 | 0.11 | Why? |
Thorax | 1 | 2020 | 1873 | 0.11 | Why? |
Delayed Diagnosis | 1 | 2020 | 1529 | 0.10 | Why? |
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1573 | 0.10 | Why? |
Adult | 7 | 2021 | 244371 | 0.10 | Why? |
Anesthesia | 1 | 2020 | 1236 | 0.10 | Why? |
Multivariate Analysis | 1 | 2021 | 5440 | 0.10 | Why? |
Workload | 1 | 2020 | 1887 | 0.10 | Why? |
Uncertainty | 1 | 2020 | 1888 | 0.09 | Why? |
Lymphocyte Count | 1 | 2021 | 4758 | 0.09 | Why? |
Recurrence | 1 | 2017 | 3675 | 0.08 | Why? |
Attitude to Health | 1 | 2020 | 2002 | 0.08 | Why? |
Occupational Stress | 1 | 2020 | 2044 | 0.08 | Why? |
Postoperative Complications | 2 | 2020 | 5861 | 0.07 | Why? |
Pilot Projects | 1 | 2017 | 5182 | 0.07 | Why? |
Time-to-Treatment | 1 | 2021 | 5883 | 0.07 | Why? |
Male | 6 | 2021 | 367725 | 0.06 | Why? |
Predictive Value of Tests | 1 | 2018 | 9537 | 0.06 | Why? |
Socioeconomic Factors | 1 | 2020 | 8495 | 0.06 | Why? |
Length of Stay | 1 | 2020 | 11042 | 0.06 | Why? |
Tertiary Care Centers | 1 | 2020 | 8248 | 0.06 | Why? |
Disease Management | 1 | 2020 | 6841 | 0.06 | Why? |
Pneumonia | 1 | 2020 | 5652 | 0.05 | Why? |
Risk Factors | 3 | 2019 | 71621 | 0.05 | Why? |
Quality of Life | 1 | 2021 | 9820 | 0.05 | Why? |
Incidence | 1 | 2021 | 25622 | 0.05 | Why? |
Follow-Up Studies | 1 | 2017 | 17020 | 0.05 | Why? |
Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
Tensile Strength | 1 | 2017 | 42 | 0.04 | Why? |
Prevalence | 1 | 2020 | 25773 | 0.04 | Why? |
Sensitivity and Specificity | 1 | 2018 | 22971 | 0.04 | Why? |
Biomarkers | 1 | 2021 | 23361 | 0.04 | Why? |
Collagen | 1 | 2017 | 222 | 0.04 | Why? |
Depression | 1 | 2020 | 14116 | 0.04 | Why? |
Materials Testing | 1 | 2017 | 380 | 0.04 | Why? |
Hospitalization | 3 | 2020 | 54280 | 0.04 | Why? |
Treatment Outcome | 1 | 2021 | 51732 | 0.03 | Why? |
Time Factors | 1 | 2017 | 31397 | 0.03 | Why? |
Cattle | 1 | 2017 | 1336 | 0.03 | Why? |
Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
Cesarean Section | 1 | 2020 | 2089 | 0.03 | Why? |
Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
Diagnosis, Differential | 1 | 2021 | 7220 | 0.02 | Why? |
Surgical Procedures, Operative | 1 | 2020 | 2662 | 0.02 | Why? |
Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.02 | Why? |
Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
Risk Assessment | 1 | 2019 | 25439 | 0.01 | Why? |
Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
Animals | 1 | 2017 | 78931 | 0.01 | Why? |
Buonomo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(84)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_